​

Funding Round

Series A - Trefoil Therapeutics

Series A - Trefoil Therapeutics

Investment Firm

Overview

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

Announced Date

Dec 01, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Hatteras Venture Partners

Hatteras Venture Partners

Hatteras Venture Partners is a convertible_note and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

1

Investor Name
Participant InvestorHatteras Venture Partners

Round Details and Background

Trefoil Therapeutics raised $28000000 on 2021-12-01 in Series A

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 01, 2021
Series A - Trefoil Therapeutics
1-28.0M
Mar 22, 2022
Venture Round - Trefoil Therapeutics
-12.0M
Oct 20, 2015
Grant - Trefoil Therapeutics
1-undefined
Jan 05, 2017
Series A - Trefoil Therapeutics
4-5.2M

Recent Activity

There is no recent news or activity for this profile.